Estrella Immunopharma Inc. Defensive Interval Ratio

Latest as of March 2026: 9 days

Estrella Immunopharma Inc. defensive interval ratio. Estrella Immunopharma Inc. (ESLA) has a Defensive Interval Ratio of 9 days as of March 2026. Defensive assets of $229.79K (cash $-, short-term investments $-, receivables $229.79K) cover 9 days of daily cash needs of $24.46K/day. See ESLA net working capital ratio to evaluate short-term liquidity relative to the company's equity base.

Defensive Interval Ratio

9 days
Days of operational coverage

Defensive Assets

$229.79K
Cash + ST Investments + Receivables

Daily Cash Need

$24.46K
Current Liabilities ÷ 365

Current Liabilities

$8.93 Million
USD

Defensive Interval Ratio of Estrella Immunopharma Inc. (2022–2024)

Defensive interval ratio of Estrella Immunopharma Inc. from 2022 to 2024. This chart shows how Estrella Immunopharma Inc.'s Defensive Interval Ratio has evolved across 2 annual periods from 2022 to 2024. As of March 2026, the ratio stands at 9 days, meaning defensive assets of $229.79K can fund 9 days of operations without new revenue. Read Estrella Immunopharma Inc. (ESLA) total liabilities for a breakdown of total debt and financial obligations.

Estrella Immunopharma Inc. Defensive Interval Ratio by Year (2022–2024)

Estrella Immunopharma Inc. defensive interval ratio by year from 2022 to 2024. The table below presents the year-by-year Defensive Interval Ratio for Estrella Immunopharma Inc. from 2022 to 2024, covering 2 annual filings. Each row shows defensive assets, daily cash need, the DIR in days, and the change in days compared to the prior year. For the complete balance sheet picture, see Estrella Immunopharma Inc. assets under control.

Year DIR (days) Defensive Assets (USD) Daily Cash Need Cash ST Investments Change (days)
2024 35 days $288.76K $8.21K/day $- $- ▼ -58 days
2022 93 days $273.07K $2.94K/day $- $- —
DIR = (Cash + Short-term Investments + Net Receivables) / (Daily Cash Expenses)